Home › Funds › CRAMER ROSENTHAL MCGLYNN LLC › BLFS

CRAMER ROSENTHAL MCGLYNN LLC position in BLFS

BIOLIFE SOLUTIONS INC · Health Care

CRAMER ROSENTHAL MCGLYNN LLC reported holding 575,792 shares of BLFS (BIOLIFE SOLUTIONS INC) in its Q2 2026 13F filing — a position valued at US$16.3M, representing 0.84% of its reported portfolio and ranking #43 among its reported holdings. CRAMER ROSENTHAL MCGLYNN LLC has disclosed BLFS holdings in 9 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)575.79K sh
Reported value held$16.26M
Portfolio Weight0.84%
First reportedQ1 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CRAMER ROSENTHAL MCGLYNN LLC's BLFS position evolved

CRAMER ROSENTHAL MCGLYNN LLC first disclosed a stake in BLFS in Q1 2024 at 1,167,228 shares (US$21.7M). The position peaked in Q2 2024 at 1,300,829 shares, worth US$27.9M. Across 9 filings, CRAMER ROSENTHAL MCGLYNN LLC increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 575,792 shares valued at US$16.3M — a reduction of -57,020 shares quarter over quarter.. Notable position changes include a 86% trim in Q3 2025 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 1.17M $21.65M New
Q2 2024 1.30M $27.88M Add
Q3 2024 1.10M $27.61M Reduce
Q4 2024 905.75K $23.51M Reduce
Q1 2025 684.38K $15.63M Reduce
Q2 2025 704.15K $15.17M Add
Q3 2025 96.59K $2.46M Reduce
Q1 2026 632.81K $12.07M New
Q2 2026 575.79K $16.26M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BLFS and 13F data

BLFS (BIOLIFE SOLUTIONS INC) is a Health Care company. 33 other funds we track also report a position in BLFS — the largest reported positions include Casdin Capital (US$131.5M), NEXT CENTURY GROWTH INVESTORS LLC (US$15.8M), GAGNON SECURITIES LLC (US$15.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BLFS

All BLFS fund holders →

FAQ

How long has CRAMER ROSENTHAL MCGLYNN LLC held BLFS?

CRAMER ROSENTHAL MCGLYNN LLC has disclosed BLFS holdings in 9 of the last 10 reported quarters, going back to Q1 2024.

What is CRAMER ROSENTHAL MCGLYNN LLC's current position in BLFS?

As of Q2 2026, CRAMER ROSENTHAL MCGLYNN LLC holds 575.79K shares of BLFS (BIOLIFE SOLUTIONS INC), valued at $16.26M, representing 0.84% of its reported portfolio and ranking #43.

Has CRAMER ROSENTHAL MCGLYNN LLC been buying or selling BLFS?

In the latest 13F filing (Q2 2026), CRAMER ROSENTHAL MCGLYNN LLC reduced its position in BLFS. The position peaked in Q2 2024 at 1.30M shares.

Which other funds hold BLFS?

Other major institutional holders of BLFS include Casdin Capital, NEXT CENTURY GROWTH INVESTORS LLC, GAGNON SECURITIES LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.